Using the Sengenics CTA protein array, pooled benign controls (n = 2, adenomas) showed detectable autoantibodies (Z-score > 3) against five antigens (AURKA, CTAG1A, CYP450 3A4, MAGEA4 and RAF1). This evidence concerns the gene CTAG1A and adenoma.